Analytical Data
-
基因名
TCEAL4
- Application
-
别名
TCEAL4; NPD017; Transcription elongation factor A Protein-like 4; TCEA-like Protein 4; Transcription elongation factor S-II Protein-like 4
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q96EI5
-
表达区间
1-215 aa
-
氨基酸序列
MEKLYSENEG MASNQGKMEN EEQPQDERKP EVTCTLEDKK LENEGKTENK GKTGDEEMLK DKGKPESEGE AKEGKSEREG ESEMEGGSER EGKPEIEGKP ESEGEPGSET RAAGKRPAED DVPRKAKRKT NKGLAHYLKE YKEAIHDMNF SNEDMIREFD NMAKVQDEKR KSKQKLGAFL WMQRNLQDPF YPRGPREFRG GCRAPRRDIE DIPYV
-
分子量
24.6 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
TCEAL4, a member of the T-cell factor (TCF) family, has garnered attention in recent years due to its role in immune regulation and potential implications in various diseases. Research indicates that TCEAL4 is involved in the transcriptional regulation of gene expression in T cells, influencing their activation and differentiation. This protein has been linked to several pathological conditions, including autoimmune diseases and cancers, where aberrant T cell responses can alter disease progression. As a result, the study of TCEAL4 and its recombinant forms has gained momentum in biomedical research. Scientists are particularly interested in understanding its molecular mechanisms, interactions with other proteins, and how it mediates signaling pathways within immune responses. Recent advances in recombinant protein technology enable the production of TCEAL4, facilitating comprehensive functional assays and structural studies. Such research endeavors aim to unravel the therapeutic potential of TCEAL4 targeting in treating immune-related disorders and improving the efficacy of immunotherapies. Furthermore, the development of TCEAL4 as a biomarker for immunological conditions is also being explored, highlighting its relevance in clinical settings. Overall, continued investigation of TCEAL4's role in immune regulation could provide significant insights into therapeutic strategies for a wide array of diseases.
